Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity

Figure 4

The association between the HbA1c reduction rate and HbA1c level at baseline (before aGLP-1 treatment).